HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails.

Abstract
Four bis(thiosemicarbazonate)gold(III) complexes (1-4) with a general formula [Au(L)]Cl {L=L1, glyoxal-bis(N(4)-methylthiosemicarbazone); L2, glyoxal-bis(N(4)-ethylthiosemicarbazone); L3, diacetyl-bis(N(4)-methylthiosemicarbazone); L4, diacetyl-bis(N(4)-ethylthiosemicarbazone)} were synthesised and screened for activity against the human immunodeficiency virus (HIV). Complexes 1-4 were characterised using (1)H-NMR and IR spectroscopy; and their purity established by micronanalysis. Complex 3 inhibited viral infection of TZM-bl cells by 98% (IC(50)=6.8±0.6μM) at a non toxic concentration of 12.5μM while complex 4 inhibited infection of these cells by 72 and 98% (IC(50)=5.3±0.4μM) at concentrations of 6.25 and 12.5μM respectively. The mechanism of inhibition of infection in TZM-bl cells is presumably as a result of the cytostatic or anti-proliferative activity that was observed for complex 4 in real time cell electronic sensing (RT-CES) and carboxyflourescein succinimidyl ester (CFSE) analysis. Treatment of T lymphocytes from HIV infected individuals with 4 decreased CD4+ T cell expression (p=0.0049) as demonstrated by multi-parametric flow cytometry without suppressing cytokine production. None of the ligands (L1-L4) demonstrated anti-viral activity, supporting the importance of metal (gold) complexation in these potential drugs. Complexes 3 and 4 were shown to have ideal lipophilicity values that were similar when shake flask (0.97±0.5 and 2.42±0.6) and in silico prediction (0.8 and 1.5) methods were compared. The activity and drug-like properties of complexes 3 and 4 suggests that these novel metal-based compounds could be combined with virus inhibitory drugs to work as cytostatic agents in the emerging class of anti-HIV drugs known as virostatics.
AuthorsPascaline N Fonteh, Frankline K Keter, Debra Meyer
JournalJournal of inorganic biochemistry (J Inorg Biochem) Vol. 105 Issue 9 Pg. 1173-80 (Sep 2011) ISSN: 1873-3344 [Electronic] United States
PMID21708102 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  • Anti-HIV Agents
  • CD4 Antigens
  • Coordination Complexes
  • Cytostatic Agents
  • Fluoresceins
  • Succinimides
  • Thiosemicarbazones
  • Gold
  • Luciferases
Topics
  • Anti-HIV Agents (chemical synthesis, pharmacology)
  • CD4 Antigens (analysis, biosynthesis)
  • CD4-Positive T-Lymphocytes (cytology, drug effects, metabolism, virology)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Coordination Complexes (chemical synthesis, pharmacology)
  • Cytostatic Agents (chemical synthesis, pharmacology)
  • Female
  • Flow Cytometry
  • Fluoresceins (analysis)
  • Genes, Reporter
  • Gold (chemistry, metabolism, pharmacology)
  • HIV Infections (drug therapy, metabolism, pathology, virology)
  • HIV-1 (drug effects, growth & development)
  • HeLa Cells
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Luciferases (analysis)
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Spectrophotometry, Infrared
  • Succinimides (analysis)
  • Thiosemicarbazones (chemical synthesis, pharmacology)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: